text: mylan nv say thursday would reduce out-of-pocket cost emergency epipen allergy injection patients amid wave criticism lawmakers public product rapidly escalate price list price drug remain company say would increase maximum copay assistance program 300 100 patients pay 2-pak cash cover commercial health insurer price epipen skyrocket 600 100 since acquire mylan 2007. mylan also say double eligibility patient assistance program eliminate out-of-pocket cost uninsured under-insured patients families government pay program eligible copay assistance program ronny gal analyst bernstein say say do estimate total price reduction epipen 32 percent price rise 27 percent second quarter 2016 versus quarter year ago thus basically roll back increase past year say estimate today news result 20-25 percent hit epipen revenues expect translate 3-4 percent hit mylan earn per share next years estimate company earn 4.77 share 2016 5.58 2017. mylan late company catch grow outrage apparently egregious drug price increase valeant pharmaceuticals international inc turing pharmaceuticals publicly excoriate similar price increase presidential candidate hillary clinton speak escalate drug price welcome fact mylan apparently open take step low cost share burden impose families tyrone gayle campaign spokesman say statement however add discount select customers without low overall price epipens insufficient excessive price likely pass high insurance premiums clinton view echo democratic lawmakers include rep. elijah cummings say mylan move nothing public relations stunt nothing help majority patients need drug offer meager discount widespread bipartisan criticism exactly tactic use drug company across industry distract exorbitant price increase say statement nobody buy pr move more mylan chief executive heather bresch defend price interview thursday cnbc say company spend hundreds millions dollars improve epipen include make needle invisible since acquire device german generic drugmaker merck kgaa pick product merck spend dollar say bresch bresch say mylan recoup less half epipen list price pharmacy benefit managers often require discount price rebate drugmakers involve along insurers others democratic u.s. senator amy klobuchar say mylan action welcome relief many struggle afford medication say address root problem rise drug cost early year clinton chastise drug company exorbitant price unveil plan say would cut cost make issue hot election discussion topic potentially issue could policy implications elect wednesday clinton press mylan voluntarily cut epipen price send company share price low push biotech stock mylan share fell 10 percent week rise 3.2 percent thursday announcement discount program epipens preloaded injections epinephrine adrenaline use case dangerous allergic reaction know anaphylaxis could cause death untreated anaphylaxis occur little couple minutes exposure allergen come form food peanuts insects be certain medications latex also cause severe reaction symptoms include itch swell lips tongue roof mouth tight chestedness difficulty breathe people susceptible reactions frequently advise carry epipen deliver immediate emergency jolt adrenaline reverse symptoms group lawmakers say wednesday write u.s. food drug administration ask approval process alternatives epipen fda spokeswoman theresa eisenman say statement agency review question pose letter respond directly congressional members note fda authority review approve drug price bresch daughter democratic u.s. senator joe manchin west virginia say contact members congress past two days ask meet discuss call unsustainable drug price system say one call senate judiciary committee chairman chuck grassley r-iowa recently write letter mylan ask explanation big epipen price increase mylan offer discount epipen amid wave criticism
input: Your task is to classify the provided input as real or fake news. Label 0 is meant for fake news, Label 1 is for real news. TEXT: mylan nv say thursday would reduce out-of-pocket cost emergency epipen allergy injection patients amid wave criticism lawmakers public product rapidly escalate price list price drug remain company say would increase maximum copay assistance program 300 100 patients pay 2-pak cash cover commercial health insurer price epipen skyrocket 600 100 since acquire mylan 2007. mylan also say double eligibility patient assistance program eliminate out-of-pocket cost uninsured under-insured patients families government pay program eligible copay assistance program ronny gal analyst bernstein say say do estimate total price reduction epipen 32 percent price rise 27 percent second quarter 2016 versus quarter year ago thus basically roll back increase past year say estimate today news result 20-25 percent hit epipen revenues expect translate 3-4 percent hit mylan earn per share next years estimate company earn 4.77 share 2016 5.58 2017. mylan late company catch grow outrage apparently egregious drug price increase valeant pharmaceuticals international inc turing pharmaceuticals publicly excoriate similar price increase presidential candidate hillary clinton speak escalate drug price welcome fact mylan apparently open take step low cost share burden impose families tyrone gayle campaign spokesman say statement however add discount select customers without low overall price epipens insufficient excessive price likely pass high insurance premiums clinton view echo democratic lawmakers include rep. elijah cummings say mylan move nothing public relations stunt nothing help majority patients need drug offer meager discount widespread bipartisan criticism exactly tactic use drug company across industry distract exorbitant price increase say statement nobody buy pr move more mylan chief executive heather bresch defend price interview thursday cnbc say company spend hundreds millions dollars improve epipen include make needle invisible since acquire device german generic drugmaker merck kgaa pick product merck spend dollar say bresch bresch say mylan recoup less half epipen list price pharmacy benefit managers often require discount price rebate drugmakers involve along insurers others democratic u.s. senator amy klobuchar say mylan action welcome relief many struggle afford medication say address root problem rise drug cost early year clinton chastise drug company exorbitant price unveil plan say would cut cost make issue hot election discussion topic potentially issue could policy implications elect wednesday clinton press mylan voluntarily cut epipen price send company share price low push biotech stock mylan share fell 10 percent week rise 3.2 percent thursday announcement discount program epipens preloaded injections epinephrine adrenaline use case dangerous allergic reaction know anaphylaxis could cause death untreated anaphylaxis occur little couple minutes exposure allergen come form food peanuts insects be certain medications latex also cause severe reaction symptoms include itch swell lips tongue roof mouth tight chestedness difficulty breathe people susceptible reactions frequently advise carry epipen deliver immediate emergency jolt adrenaline reverse symptoms group lawmakers say wednesday write u.s. food drug administration ask approval process alternatives epipen fda spokeswoman theresa eisenman say statement agency review question pose letter respond directly congressional members note fda authority review approve drug price bresch daughter democratic u.s. senator joe manchin west virginia say contact members congress past two days ask meet discuss call unsustainable drug price system say one call senate judiciary committee chairman chuck grassley r-iowa recently write letter mylan ask explanation big epipen price increase mylan offer discount epipen amid wave criticism